ICAM-1 as a Molecular Target for Triple Negative Breast Cancer

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.1408556111
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Mesothelin, a Novel Immunotherapy Target for Triple Negative Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2012English

Molecular Stratification Within Triple-Negative Breast Cancer Subtypes

Scientific Reports
Multidisciplinary
2019English

Tissue Factor as a New Target for CAR-NK Cell Immunotherapy of Triple-Negative Breast Cancer

Scientific Reports
Multidisciplinary
2020English

The Association of ICAM-1 Detected by Immunohistochemical Staining With Triple Negative and Non-Triple Negative Breast Carcinoma

Sains Malaysiana
Multidisciplinary
2019English

Brachyury, a Vaccine Target, Is Overexpressed in Triple-Negative Breast Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2016English

Estrogen Receptor-Beta Is a Potential Target for Triple Negative Breast Cancer Treatment

Oncotarget
Oncology
2018English

Triple-Negative Breast Cancer

2018English

Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer

Scientific Reports
Multidisciplinary
2019English

A Review of Triple-Negative Breast Cancer

Cancer Control
MedicineOncologyHematology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy